- Zacks•4 days ago
AVEO Pharmaceuticals, Inc. (AVEO) reported a narrower-than-expected loss in the fourth-quarter 2016.
- Associated Press•5 days ago
The Cambridge, Massachusetts-based company said it had a loss of 7 cents per share. Losses, adjusted for non-recurring gains, came to 11 cents per share. The cancer drug company posted revenue of $127,000 ...
- Business Wire•5 days ago
AVEO Oncology today reported financial results for the full year ended December 31, 2016 and provided a business update.
AVEO : Summary for AVEO Pharmaceuticals, Inc. - Yahoo Finance
AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||0.64 x 300|
|Day's Range||0.64 - 0.68|
|52 Week Range||0.54 - 1.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.48|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|